FIBROTHERA
FIBROTHERA
EN

Diseminare

Prima pagina » 

Articole publicate

2026

  1. Simona Greco S, Perego F, Piella SN, Favretto F, Tastsoglou S, Milani V, Boveri S, Renna LV, Cardani R, Ambrogi F, Nano G, Basilico N, Mazzaccaro D, Martelli F. Diagnostic potential of circular RNAs in carotid atherosclerotic plaque vulnerability. Non-coding RNA Res. 2026 Mar 4:18:118-127. doi: 10.1016/j.ncrna.2026.02.001. PMID: 41809636 PMCID: PMC12969012. (https://pubmed.ncbi.nlm.nih.gov/41809636/) (Q1)
  2. Tikhomirov R, Boichenko V, Reilly-O'Donnell B, Lucarelli C, Srivastava PK, Anwar M, Yiu CHK, Dielesen J, Noakes VM, Piella SN, Kazharova D, Labbé M, Kwan Z, Zaccagnini G, Mansfield C, Tessari M, Menicanti L, Greco S, Sweeney M, Okafor J, Leszek P, Faggian G, Luciani GB, Emanueli C, Martelli F, Gorelik J. Interleukin 11-Induced MicroRNAs as Functional Mediators and Circulating Biomarkers of Cardiac Fibrosis. Circ Res. 2026 Apr 24;138(9):e326799. doi: 10.1161/CIRCRESAHA.125.326799. PMID: 41841256, PMCID: PMC13108434 (https://pubmed.ncbi.nlm.nih.gov/41841256/) (Q1)
  3. Barbi V, Romeo MA, Gottardi Zamperla M, Favretto F, Atlante S, Lucotti A, Gaetano C, Martelli F. Emergent RNA targets in cardiovascular disease: likely candidates for treatment development. Expert Opin Ther Targets. 2026 Apr;30(4):343-356. doi: 10.1080/14728222.2026.2671679. PMID: 42171621 (https://pubmed.ncbi.nlm.nih.gov/42171621/) (Q1)
  4. Macarie RD, Țucureanu MM, Ciortan L, Preda MB, Mânduțeanu I, Butoi E (2026) Osteopontin-expressing valvular interstitial cell subpopulation as a driver of extracellular matrix remodeling in aortic valve disease. Front. Cardiovasc. Med. 2026 Apr 7:13:1755830. doi: 10.3389/fcvm.2026.1755830. PMID: 42022532, PMCID: PMC13095520. https://pubmed.ncbi.nlm.nih.gov/42022532/ (Q2)
  5. Sopic M, Stopa V, Munjas J, Davidović A, Vukmirović L, Cvijanović D, Milanov M, Martelli F, Bernardin F, Legrave NM, Devaux Y. RNA modifications in peripheral blood are associated with acute coronary syndrome. J Mol Cell Cardiol Plus. 2026 Mar 4:15:100839. doi: 10.1016/j.jmccpl.2026.100839. PMID: 41815326, PMCID: PMC12972519 (https://pubmed.ncbi.nlm.nih.gov/41815326/) (Q1)

2025

  1. Fanfulla F, Barbi V, Bachetti T, Maestri R, Robbi E, Mongelli A, Aloi TL, Pronzato C, Gottardi Zamperla M, Greco S, Martelli F, La Rovere MT, Gaetano C. Modulation of hypoxia-sensitive non-coding RNAs following continuous positive airway pressure therapy in obstructive sleep apnea in peripheral blood. Eur J Intern Med. 2025 Nov:141:106393. doi: 10.1016/j.ejim.2025.06.022. PMID: 40603222 (https://pubmed.ncbi.nlm.nih.gov/40603222/) (Q1)
  2. Baci D, Tastsoglou S, Provenzano C, Perfetti A, Izzo M, Lisanti M, Frolova S, Voellenkle C, Tascini AS, Cardani R, Cardinali B, Meola G, Falcone G, Martelli F. circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1. Mol Ther Nucleic Acids. 2025 Jul 30;36(3):102646. doi: 10.1016/j.omtn.2025.102646. PMID: 40896579, PMCID: PMC12395532. (https://pubmed.ncbi.nlm.nih.gov/40896579/) (Q1)
  3. Mitić T, Georgescu A, Alexandru-Moise N, Davies MJ, Vindis C, Novella S, Gerdts E, Kararigas G, Wettinger SB, Formosa MM, Kwak BR, Molica F, Amigo N, Caporali A, de la Cuesta F, Hall IF, Chroni A, Martelli F, Schmid JA, Magni P, Kardassis D; COST Action AtheroNET (CA21153). Current status and challenges of multi-omics research using animal models of atherosclerosis. J Mol Cell Cardiol Plus. 2025 Jul 10:13:100476. doi: 10.1016/j.jmccpl.2025.100476. PMID: 40726539, PMCID: PMC12301843 (https://pubmed.ncbi.nlm.nih.gov/40726539/) (Q1)
  4. Boichenko V, Noakes VM, Reilly-O'Donnell B, Luciani GB, Emanueli C, Martelli F, Gorelik J. Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity. Cells. 2025 Apr 7;14(7):553. doi: 10.3390/cells14070553. PMID: 40214506, PMCID: PMC11989213 (https://pubmed.ncbi.nlm.nih.gov/40214506/) (Q2)
  5. Collado A, Jiao T, Kontidou E, Carvalho LRRA, Chernogubova E, Yang J, Zaccagnini G, Zhao A, Tengbom J, Zheng X, Rethi B, Alvarsson M, Catrina SB, Mahdi A, Carlström M, Martelli F, Pernow J, Zhou Z. miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction. Br J Pharmacol. 2025 Jan;182(2):417-431. doi: 10.1111/bph.17329. PMID: 39402703 (https://pubmed.ncbi.nlm.nih.gov/39402703/) (Q1)
  6. Bibi A, Madè A, Greco S, Garcia-Manteiga JM, Tascini AS, Tastsoglou S, Zaccagnini G, Leszek P, Gaetano C, Martelli F. Circular PVT1 promotes cardiac fibroblast activation interacting with miR-30a-5p and miR-125b-5p. Cell Death Dis. 2025 Apr 21;16(1):325. doi: 10.1038/s41419-025-07652-7. PMID: 40258819; PMCID: PMC12012019. (https://pubmed.ncbi.nlm.nih.gov/40258819/) (Q1)
  7. Marinescu-Colan CI, Nastase-Rusu EG, Neculachi CA, Martelli F, Cherry L, Preda MB, Burlacu A. From cancer to heart fibrosis - GLIPR1 highlights a subset of myofibroblasts responsive to mesenchymal stem cell therapy after myocardial infarction. Biomed Pharmacother. 2025 Jun;187:118087. doi: 10.1016/j.biopha.2025.118087. https://pubmed.ncbi.nlm.nih.gov/40306172/ (Q1)
  8. Preda MB, Nastase-Rusu EG, Neculachi CA, Zhong X, Voellenkle C, Mazure NM, Balacescu O, Ivan C, Zheng XW, Gherghiceanu M, Lebrigand K, Simionescu M, Martelli F, Mari B, Catrina SB, Burlacu A, Ivan M. miR-210 locus deletion disrupts cellular homeostasis: an integrated genetic study. Sci Rep. 2025 Jul 2;15(1):22659. doi: 10.1038/s41598-025-07572-8. PMID: 40595052; PMCID: PMC12217331. https://pubmed.ncbi.nlm.nih.gov/40595052/ (Q1)
  9. Cherry L, Popescu S, Neculachi CA, Nastase-Rusu EG, Marinescu-Colan CI, Cosman BP, Ciortan L, Martelli F, Simionescu M, Butoi E, Burlacu A, Preda MB. Mesenchymal stromal cells modulate neutrophil phenotype via paracrine signals. Stem Cell Res Ther. 2025 Oct 21;16(1):574. doi: 10.1186/s13287-025-04684-w. https://pubmed.ncbi.nlm.nih.gov/41121373/ (Q1)
  10. Neculachi CA, Nastase-Rusu EG, Cherry L, Marinescu-Colan CI, Tastsoglou S, Cosman BP, Popa AM, Panciuc C, Zaccagnini G, Catrina SB, Simionescu M, Martelli F, Preda MB, Burlacu A. miR-210 promotes the anti-inflammatory phenotype and M2 polarization in murine macrophages. Front Immunol. 2025 Aug 5;16:1633163. doi: 10.3389/fimmu.2025.1633163. https://pubmed.ncbi.nlm.nih.gov/40837585/ (Q1)

2024

  1. Caporali A, Anwar M, Devaux Y, Katare R, Martelli F, Srivastava PK, Pedrazzini T, Emanueli C. Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease. Nat Rev Cardiol. 2024 Aug;21(8):556-573. doi: 10.1038/s41569-024-01001-5. PMID: 38499868 (https://pubmed.ncbi.nlm.nih.gov/38499868/) (Q1)
  2. Zaccagnini G, Baci D, Tastsoglou S, Cozza I, Madè A, Voellenkle C, Nicoletti M, Ruatti C, Longo M, Perani L, Gaetano C, Esposito A, Martelli F. miR-210 over-expression increases pressure overload-induced cardiac fibrosis. Non-coding RNA Research, 2025, Jan 31:12:20-33. doi: 10.1016/j.ncrna.2025.01.009. PMID: 40034123, PMCID: PMC11874870. (https://pubmed.ncbi.nlm.nih.gov/40034123/) (Q1)
  3. Mihaila AC, Ciortan L, Tucureanu MM, Simionescu M, Butoi E. Anti-Inflammatory Neutrophils Reprogram Macrophages toward a Pro-Healing Phenotype with Increased Efferocytosis Capacity. Cells. 2024 Jan 23;13(3):208. doi: 10.3390/cells13030208. PMID: 38334600; PMCID: PMC10854927. https://pubmed.ncbi.nlm.nih.gov/38334600/ (Q2)
  4. Iacobescu L, Ciobanu AO, Macarie R, Vadana M, Ciortan L, Tucureanu MM, Butoi E, Simionescu M, Vinereanu D. Diagnostic and Prognostic Role of Circulating microRNAs in Patients with Coronary Artery Disease-Impact on Left Ventricle and Arterial Function. Curr Issues Mol Biol. 2024 Aug 3;46(8):8499-8511. doi: 10.3390/cimb46080500. PMID: 39194717; PMCID: PMC11352712. https://pubmed.ncbi.nlm.nih.gov/39194717/ (Q3)